查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957491

2026年全球神經再生療法市場報告

Neuroregeneration Therapy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，神經再生療法的市場規模迅速擴張。預計該市場規模將從2025年的112.9億美元成長到2026年的127.5億美元，複合年成長率（CAGR）為12.9%。過去幾年成長要素包括：神經再生療法的普及程度有限、神經退化性疾病的高發生率、神經修復臨床研究的增加、人們對神經系統疾病管理的認知不斷提高，以及對傳統藥物治療的依賴。

預計未來幾年神經再生療法市場將快速成長，到2030年將達到205億美元，複合年成長率（CAGR）為12.6%。預測期內的成長要素包括：先進幹細胞和基因療法的開發、神經刺激設備應用範圍的擴大、人工智慧和數位監測技術在治療中的應用、政府對神經學研究投入的增加，以及製藥和生物技術公司之間合作的加強。預測期內的關鍵趨勢包括：幹細胞和基因療法在神經再生領域的應用日益廣泛、神經刺激技術在臨床實踐中的應用不斷擴大、以神經保護為靶點的治療方法發展迅速、奈米技術和生物材料在藥物遞送領域的應用不斷擴展，以及針對神經退化性疾病的個性化治療方法的整合。

神經系統疾病盛行率的上升預計將推動神經再生療法市場的成長。神經系統疾病是指影響大腦、脊髓和周邊神經，擾亂正常神經系統功能的疾病。環境毒素是導致此現象增加的因素之一；長期暴露於重金屬、殺蟲劑和工業化學等污染物會損害神經系統，並增加神經退化性疾病的風險。神經再生療法透過修復和替換受損的神經細胞和組織來治療這些疾病，恢復喪失的功能，並促進大腦、脊髓和神經的癒合。這最終可以改善運動功能、感覺功能和整體生活品質。例如，2023年10月，總部位於英國的世界神經病學聯合會（WFN，一個由各國神經病學會組成的聯盟）報告稱，全球超過40%的人口將患有某種形式的神經系統疾病，預計到2050年，這一負擔將幾乎加倍。因此，神經系統疾病盛行率的上升正在推動神經再生療法市場的成長。

社會老化預計也將推動市場成長。在老年人口比例不斷上升的社會中，隨著醫療保健和生活水準的提高，預期壽命延長，神經功能衰退的風險也隨之增加。神經再生療法透過修復受損的神經細胞、改善大腦功能和運動技能以及延緩認知衰退，最終提高老年人的生活品質。例如，根據英國圖書館2024年7月發布的報告，2022年英國65歲及以上人口約佔總人口的19%（約1,270萬人），預計到2072年將增加至2,210萬人（27%）。因此，人口老化正在推動神經再生療法市場的成長。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球神經再生療法市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 幹細胞和基因療法在神經再生的應用日益廣泛
    • 擴大神經刺激技術在臨床環境的應用
    • 針對神經保護的藥物治療方法的發展
    • 奈米技術和生物材料在藥物傳遞領域的拓展
    • 整合針對神經退化性疾病的個人化治療方法

第5章 終端用戶產業市場分析

  • 醫院
  • 臨床研究機構
  • 學術機構
  • 製藥和生物技術公司
  • 復健中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球神經再生療法市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和抑制因素）
  • 全球神經再生療法市場規模、對比及成長率分析
  • 全球神經再生療法市場表現：規模與成長，2020-2025年
  • 全球神經再生療法市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 神經再生療法的類型
  • 幹細胞療法、基因療法、藥物療法、神經刺激療法和其他神經再生療法
  • 透過技術
  • 組織工程、顱腦及脊髓刺激療法、藥物傳遞奈米技術、生物材料開發
  • 透過行政途徑
  • 口服、注射、植入等給藥方式
  • 指示
  • 脊髓損傷、創傷性腦損傷、中風、巴金森氏症、多發性硬化症、阿茲海默症、周邊神經損傷及其他適應症。
  • 最終用戶
  • 醫院、臨床研究機構、學術機構、製藥和生物技術公司
  • 按類型細分：幹細胞療法
  • 胚胎幹細胞療法、間質幹細胞療法、神經幹細胞療法、誘導性多功能細胞療法、造血幹細胞療法
  • 按類型細分：基因治療
  • 體內基因治療、體外基因治療、以病毒載體為基礎的基因治療、基於非病毒載體的基因治療、基因組編輯基因治療
  • 按類型細分：藥物治療
  • 神經保護藥物、神經營養因子類藥物、抗發炎藥物、抗氧化劑
  • 按類型細分：神經刺激療法
  • 深部腦部刺激、經顱磁刺激、迷走神經刺激、脊髓刺激、經顱直流電刺激
  • 按類型細分：其他神經再生療法
  • 以奈米技術為基礎的療法、以外泌體為基礎的療法、以生物材料為基礎的療法

第10章 區域與國別分析

  • 全球神經再生療法市場：按地區分類，實際數據和預測數據，2020-2025年、2025-2030年、2035年
  • 全球神經再生療法市場：按國家/地區分類，實際數據和預測數據，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 神經再生療法市場：競爭格局及市場佔有率（2024年）
  • 神經再生療法市場：公司評估矩陣
  • 神經再生療法市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Sanofi SA
    • Novartis International AG

第37章 其他大型企業和創新企業

  • Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics BV, Epineuron Technologies Inc., NeuExcell Therapeutics Inc

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年神經再生療法市場：提供新機會的國家
  • 2030年神經再生療法市場：蘊藏新機會的細分市場
  • 2030年神經再生療法市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH5MNTHE01_G26Q1

Neuroregeneration therapy encompasses medical interventions aimed at repairing, regenerating, or replacing damaged neurons and neural tissues in the brain, spinal cord, or peripheral nerves. Its primary objective is to restore neurological functions that have been lost due to injury, disease, or degenerative disorders.

The main types of neuroregeneration therapy include stem cell therapy, gene therapy, pharmacological therapy, neurostimulation therapy, and other approaches. Stem cell therapy involves the use of stem cells to repair, replace, or regenerate damaged or diseased cells, tissues, or organs. These therapies employ various technologies such as tissue engineering, cranial and spinal stimulation, nanotechnology-based drug delivery, and biomaterials development. They can be administered through multiple routes, including oral, injectable, and implantable methods. Neuroregeneration therapies are applied to a range of indications, including spinal cord injury, traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, Alzheimer's disease, and peripheral nerve injury. Key end users include hospitals, clinical research institutes, academic institutions, and pharmaceutical and biotechnology companies.

Tariffs have impacted the neuroregeneration therapy market by increasing the cost of imported stem cell products, gene therapy vectors, neurostimulation devices, and biomaterials. Segments such as stem cell therapy, gene therapy, and advanced neurostimulation are most affected, particularly in North America, Europe, and Asia-Pacific regions reliant on imports. This has resulted in higher therapy costs and slowed adoption in some regions. However, tariffs have also encouraged domestic production, innovation in neuroregeneration technologies, and investment in local manufacturing capacities.

The neuroregeneration therapy market research report is one of a series of new reports from The Business Research Company that provides neuroregeneration therapy market statistics, including neuroregeneration therapy industry global market size, regional shares, competitors with a neuroregeneration therapy market share, detailed neuroregeneration therapy market segments, market trends and opportunities, and any further data you may need to thrive in the neuroregeneration therapy industry. This neuroregeneration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroregeneration therapy market size has grown rapidly in recent years. It will grow from $11.29 billion in 2025 to $12.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to limited availability of neuroregeneration therapies, high prevalence of neurodegenerative diseases, growing clinical research on neural repair, rising awareness of neurological disorder management, reliance on conventional pharmacological treatments.

The neuroregeneration therapy market size is expected to see rapid growth in the next few years. It will grow to $20.5 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to development of advanced stem cell and gene therapies, expansion of neurostimulation device applications, integration of AI and digital monitoring in therapy, increasing government funding for neurological research, rising collaborations between pharma and biotech companies. Major trends in the forecast period include rising adoption of stem cell and gene therapies for neuroregeneration, increasing use of neurostimulation techniques in clinical practice, growth in pharmacological therapies targeting neuroprotection, expansion of nanotechnology and biomaterials in drug delivery, integration of personalized therapy approaches for neurodegenerative disorders.

The rising prevalence of neurological disorders is expected to propel the growth of the neuroregeneration therapy market going forward. Neurological disorders are conditions that affect the brain, spinal cord, or peripheral nerves, disrupting normal nervous system function. This increase is partly due to environmental toxins, as chronic exposure to pollutants such as heavy metals, pesticides, and industrial chemicals can damage the nervous system and elevate the risk of neurodegenerative diseases. Neuroregeneration therapy addresses these disorders by repairing or replacing damaged neurons and tissues, restoring lost functions and promoting healing in the brain, spinal cord, or nerves, thereby improving mobility, sensation, and overall quality of life. For instance, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that more than 40% of the global population experiences some form of neurological condition, with this burden expected to nearly double by 2050. Therefore, the rising prevalence of neurological disorders is driving the growth of the neuroregeneration therapy market.

The growing aging population is also expected to fuel market growth. Aging populations, defined by an increasing proportion of elderly individuals in society, face higher risks of neurological decline due to longer life expectancy from improved healthcare and living standards. Neuroregeneration therapy benefits this demographic by repairing damaged nerve cells, enhancing brain function and mobility, and slowing cognitive decline, ultimately improving quality of life. For instance, in July 2024, the House of Commons Library reported that in 2022, individuals aged 65 and over represented approximately 19% of the UK population (around 12.7 million), projected to grow to 22.1 million (27%) by 2072. Therefore, the rising aging population is driving the growth of the neuroregeneration therapy market.

Major companies in the neuroregeneration therapy market are focusing on innovative solutions, such as 3D-printed regenerative medical implants, which provide advanced treatment options for nerve repair and functional recovery. These implants use patient-specific biomaterials and tissue-engineered scaffolds to guide axonal growth, offering improved outcomes compared with traditional autografts or synthetic conduits limited by donor tissue availability and less customizable designs. For instance, in June 2025, 3D Systems Inc., a US-based 3D printing and medical technology company, introduced a peripheral nerve implant to facilitate targeted neuroregeneration. The implant is composed of biocompatible, 3D-printed scaffolds engineered to guide nerve regrowth, providing structural and biochemical cues that promote axonal extension and reconnection. Its unique features include patient-specific customization, integration with surrounding tissue, and compatibility with peripheral nerve repair procedures. Applications include peripheral nerve injury repair, functional restoration after trauma or surgery, and neuroregenerative research, with benefits such as accelerated recovery, improved functional outcomes, and reduced dependence on donor grafts.

Major companies operating in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.

North America was the largest region in the neuroregeneration therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroregeneration therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroregeneration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroregeneration therapy market consists of revenues earned by entities by providing services such as biomaterial implantation services, surgical interventions for nerve repair, and consulting and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroregeneration therapy market also includes sales of biomaterials, neurostimulation and neuromodulation devices, pharmaceuticals, and neural electrode arrays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroregeneration Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neuroregeneration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroregeneration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroregeneration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy; Gene Therapy; Pharmacological Therapy; Neurostimulation Therapy; Other Types Of Neuroregeneration Therapy
  • 2) By Technology: Tissue Engineering; Cranial And Spinal Stimulation; Nanotechnology In Drug Delivery; Biomaterials Development
  • 3) By Mode Of Administration: Oral; Injectable; Implantable; Other Modes Of Administration
  • 4) By Indication: Spinal Cord Injury; Traumatic Brain Injury; Stroke; Parkinson's Disease; Multiple Sclerosis; Alzheimer's Disease; Peripheral Nerve Injury; Other Indications
  • 5) By End-User: Hospitals; Clinical Research Institutes; Academic Institutions; Pharmaceutical And Biotechnology Companies
  • Subsegments:
  • 1) By Stem Cell Therapy: Embryonic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Neural Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Hematopoietic Stem Cell Therapy
  • 2) By Gene Therapy: In Vivo Gene Therapy; Ex Vivo Gene Therapy; Viral Vector Based Gene Therapy; Non Viral Vector Based Gene Therapy; Genome Editing Gene Therapy
  • 3) By Pharmacological Therapy: Neuroprotective Drugs; Neurotrophic Factor Based Drugs; Anti Inflammatory Drugs; Antioxidant Drugs
  • 4) By Neurostimulation Therapy: Deep Brain Stimulation; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation; Spinal Cord Stimulation; Transcranial Direct Current Stimulation
  • 5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy; Exosome Based Therapy; Biomaterial Based Therapy
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; Novartis International AG; Stryker Corporation; Biogen Inc.; Synovis Life Technologies Inc.; Integra LifeSciences Holdings Corporation; AxoGen Inc.; Denali Therapeutics Inc.; Aspen Neuroscience Inc.; Neurona Therapeutics Inc.; Lineage Cell Therapeutics Inc.; Checkpoint Surgical Inc.; Stemedica Cell Technologies Inc.; Polyganics B.V.; Epineuron Technologies Inc.; NeuExcell Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neuroregeneration Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neuroregeneration Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neuroregeneration Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neuroregeneration Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Stem Cell And Gene Therapies For Neuroregeneration
    • 4.2.2 Increasing Use Of Neurostimulation Techniques In Clinical Practice
    • 4.2.3 Growth In Pharmacological Therapies Targeting Neuroprotection
    • 4.2.4 Expansion Of Nanotechnology And Biomaterials In Drug Delivery
    • 4.2.5 Integration Of Personalized Therapy Approaches For Neurodegenerative Disorders

5. Neuroregeneration Therapy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Research Institutes
  • 5.3 Academic Institutions
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Rehabilitation Centers

6. Neuroregeneration Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuroregeneration Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neuroregeneration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neuroregeneration Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neuroregeneration Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neuroregeneration Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuroregeneration Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuroregeneration Therapy Market Segmentation

  • 9.1. Global Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Other Types Of Neuroregeneration Therapy
  • 9.2. Global Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Engineering, Cranial And Spinal Stimulation, Nanotechnology In Drug Delivery, Biomaterials Development
  • 9.3. Global Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral, Injectable, Implantable, Other Modes Of Administration
  • 9.4. Global Neuroregeneration Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Injury, Traumatic Brain Injury, Stroke, Parkinson's Disease, Multiple Sclerosis, Alzheimer's Disease, Peripheral Nerve Injury, Other Indications
  • 9.5. Global Neuroregeneration Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical Research Institutes, Academic Institutions, Pharmaceutical And Biotechnology Companies
  • 9.6. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Neural Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Hematopoietic Stem Cell Therapy
  • 9.7. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector Based Gene Therapy, Non Viral Vector Based Gene Therapy, Genome Editing Gene Therapy
  • 9.8. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neuroprotective Drugs, Neurotrophic Factor Based Drugs, Anti Inflammatory Drugs, Antioxidant Drugs
  • 9.9. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Neurostimulation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deep Brain Stimulation, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, Transcranial Direct Current Stimulation
  • 9.10. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Other Types Of Neuroregeneration Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nanotechnology Based Therapy, Exosome Based Therapy, Biomaterial Based Therapy

10. Neuroregeneration Therapy Market Regional And Country Analysis

  • 10.1. Global Neuroregeneration Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neuroregeneration Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuroregeneration Therapy Market

  • 11.1. Asia-Pacific Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuroregeneration Therapy Market

  • 12.1. China Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuroregeneration Therapy Market

  • 13.1. India Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuroregeneration Therapy Market

  • 14.1. Japan Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuroregeneration Therapy Market

  • 15.1. Australia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuroregeneration Therapy Market

  • 16.1. Indonesia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuroregeneration Therapy Market

  • 17.1. South Korea Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuroregeneration Therapy Market

  • 18.1. Taiwan Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuroregeneration Therapy Market

  • 19.1. South East Asia Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuroregeneration Therapy Market

  • 20.1. Western Europe Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuroregeneration Therapy Market

  • 21.1. UK Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuroregeneration Therapy Market

  • 22.1. Germany Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuroregeneration Therapy Market

  • 23.1. France Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuroregeneration Therapy Market

  • 24.1. Italy Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuroregeneration Therapy Market

  • 25.1. Spain Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuroregeneration Therapy Market

  • 26.1. Eastern Europe Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuroregeneration Therapy Market

  • 27.1. Russia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuroregeneration Therapy Market

  • 28.1. North America Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuroregeneration Therapy Market

  • 29.1. USA Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuroregeneration Therapy Market

  • 30.1. Canada Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuroregeneration Therapy Market

  • 31.1. South America Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuroregeneration Therapy Market

  • 32.1. Brazil Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuroregeneration Therapy Market

  • 33.1. Middle East Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuroregeneration Therapy Market

  • 34.1. Africa Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuroregeneration Therapy Market Regulatory and Investment Landscape

36. Neuroregeneration Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Neuroregeneration Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neuroregeneration Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neuroregeneration Therapy Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

37. Neuroregeneration Therapy Market Other Major And Innovative Companies

  • Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc

38. Global Neuroregeneration Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuroregeneration Therapy Market

40. Neuroregeneration Therapy Market High Potential Countries, Segments and Strategies

  • 40.1 Neuroregeneration Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neuroregeneration Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neuroregeneration Therapy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer